Recently, novel dietary approaches have been developed that aim to preserve health and prevent noncommunicable diseases (NCDs) such as rheumatoid arthritis and inflammatory bowel disease. An extensive body of scientific work indicates that dietary phenolic compounds have antioxidant, anti-inflammatory and antiproliferative activities that impact human health. An extensive review recently published in Pharmaceutics by Rosa Direito, Ph.D., of the Research Institute for Medicines (iMed.ULisboa) in Lisbon, Portugal, reports that new delivery systems within the field of nanotechnology could improve the efficiency of phenolic compounds when ingested by humans, providing health benefits in the form of prevention, treatment or as a complement to conventional pharmacological treatments.